Dexelvucitabine Completed Phase 1 Trials for Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00040274A Study of DPC 817 in HIV-Infected Males